IDEXX Laboratories Inc
NASDAQ:IDXX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
US |
|
5N Plus Inc
TSX:VNP
|
CA |
|
American Express Co
NYSE:AXP
|
US |
|
Caribou Biosciences Inc
NASDAQ:CRBU
|
US |
|
Reliance Steel & Aluminum Co
NYSE:RS
|
US |
|
AVEVA Group PLC
LSE:AVV
|
UK |
|
China Security Co Ltd
SSE:600654
|
CN |
|
iRobot Corp
NASDAQ:IRBT
|
US |
|
Nexus Infrastructure PLC
LSE:NEXS
|
UK |
|
P
|
PetroVietnam Drilling & Well Service Corp
VN:PVD
|
VN |
|
Steel Dynamics Inc
NASDAQ:STLD
|
US |
Wall Street
Price Targets
IDXX Price Targets Summary
IDEXX Laboratories Inc
According to Wall Street analysts, the average 1-year price target for
IDXX
is 768.59 USD
with a low forecast of 479.96 USD and a high forecast of 864.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IDXX's stock price target?
Price Target
768.59
USD
According to Wall Street analysts, the average 1-year price target for
IDXX
is 768.59 USD
with a low forecast of 479.96 USD and a high forecast of 864.15 USD.
What is IDEXX Laboratories Inc's Revenue forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
IDEXX Laboratories Inc's revenue is
9%.
The projected
CAGR
for the next 3 years is
10%.
What is IDEXX Laboratories Inc's Operating Income forecast?
Projected CAGR
12%
For the last 14 years the
compound annual growth rate for
IDEXX Laboratories Inc's operating income is
13%.
The projected
CAGR
for the next 3 years is
12%.
What is IDEXX Laboratories Inc's Net Income forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
IDEXX Laboratories Inc's net income is
14%.
The projected
CAGR
for the next 3 years is
13%.
